ELISA – Multimedia

At high levels, host cell proteins (HCPs) can cause immunogenic responses and reduced efficacy of biologics, so it is imperative to have an effective, robust HCP assay to detect them and mitigate these effects.

Download this whitepaper to discover how next-generation ELISA technology can accelerate biomarker discovery and provide in-depth analysis of COVID-19 host cytokine levels.

Download this app note to discover an automated SARS-CoV-2 IgG Ab ELISA workflow that delivers stable assay performance across the entire plate and produces more than 1,000 results in 11 hours.

Download this guide to learn more about how to ensure the success of your ELISA experiments.

Assays, such as the enzyme-linked immunosorbent assay (ELISA), are being developed to detect the presence of anti-SARS-CoV-2 antibodies in patient sera. Download this article to discover an ELISA that is more sensitive than a lateral flow immunoassay.

Download this guide for tips on choosing the most appropriate antibodies and buffers, maintaining sample quality, washing techniques, detecting multiple targets and monitoring assay performance.

Download this whitepaper to discover approaches for the detection and quantification of HCPs that streamline the process of impurity monitoring, have broad sample applicability through mass spectrometry and consider patient safety, product stability and purity.

Download this guide to learn the importance of context in optimization, why controls can make or break an assay and how sample status may be confirmed in an antibody-independent manner.

Antibodies are a vital part of the immune system, playing a key role in our ability to fight infection and in the efficacy of vaccinations. However, that’s not where their utility ends. Find out about what antibodies are, where they come from, how they function and how science is putting them to work in the laboratory.

Download this whitepaper to learn more about BLI technology, and the benefits associated with its use.